adenosine diphosphate has been researched along with mitoxantrone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, P; Novak, RF | 1 |
| Cervenak, J; Köblös, G; Koomen, GJ; Német, K; Ozvegy-Laczka, C; Sarkadi, B; Schuetz, JD; Sorrentino, BP; Ujhelly, O; Váradi, A; Várady, G | 1 |
| Ahmed-Belkacem, A; Di Pietro, A; Perez-Victoria, JM; Pozza, A; Sardo, A | 1 |
3 other study(ies) available for adenosine diphosphate and mitoxantrone
| Article | Year |
|---|---|
Mitoxantrone and bisantrene inhibition of platelet aggregation and prostaglandin E2 production in vitro.
Topics: Adenosine Diphosphate; Adult; Anthracenes; Anthraquinones; Blood Platelets; Collagen; Dinoprostone; Epinephrine; Humans; Mitoxantrone; Platelet Aggregation; Prostaglandins E | 1985 |
Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzimidazoles; Catalysis; Cell Line; Cell Membrane; Cell Separation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Hydrolysis; Immunoblotting; Insecta; Ligands; Mitoxantrone; Mutation; Neoplasm Proteins; Protein Binding; Protein Conformation; Substrate Specificity; Time Factors; Vanadates | 2005 |
Purification of breast cancer resistance protein ABCG2 and role of arginine-482.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amino Acid Substitution; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Membrane; Cloning, Molecular; DNA Primers; Drug Resistance, Multiple; Female; Humans; Kinetics; Mitoxantrone; Mutagenesis, Site-Directed; Neoplasm Proteins; Recombinant Proteins; Vanadates | 2006 |